The paper by Figueroa-Lozano et al., 2020, described earlier for Lf’s inhibition of TLR8 activation, also demonstrated similar efficacy to chloroquine, a drug that has been investigated for use in COVID-19 patients [125], although use of chloroquine for COVID-19 has not demonstrated clinical efficacy [126]. Here, TLR8 is linked to COVID-19.